Pigmented lesion is a kind of skin disease, wherein black, brown, or blue lesions appear on the skin. These lesions are usually referred to as melanocytic proliferations. Skin pigmentation may occur due to melanin, the blood, or exogenous pigments such as tattoos. In a few scenarios, the proliferation of pigmented lesions or lesions on the exposed skin may lead to skin cancer. Pigmented lesions can broadly be classified into two distinct forms: melanocytic lesions and non-melanocytic lesions. Melanocytic lesions is the most common form of skin pigmentation and it can further be classified into benign and malignant forms. On the other hand, non-melanocytic lesions may also be pigmented, the occurrence of which is more prevalent among dark-skinned individuals. In a majority of cases, malignant lesions appear anomalous under microscopic examinations and they indicate presence of cancerous tissues. Thus, removal of melanocytic lesions diminishes the proliferation and incidence of any form of malignant skin diseases. Occurrence of pigmented lesions is more common among geriatric population. These lesions mostly appear on the face. However, marks may emerge on other body parts also. Occurrence of pigmented lesions can be attributed to photo-damage i.e. continuous exposure to ultraviolet (UV) radiations or aging. Currently, pigmented lesions are treated by a wide spectrum of therapies and medications, including laser treatment. Preference for minimally invasive treatment options has gained momentum in recent times.
Growing geriatric population across the world has been a major factor contributing to the pigmented lesion treatment market. Increasing intake of toxic substances through smoking and drinking has also led to growing incidence of pigmented lesions. Other factors, such as increasing adoption of synthetic cosmetic products, are also driving the pigmented lesion treatment market. Introduction of innovative medications and treatment options, which are safe, reliable, and with minimal or no side effects, is also likely to augment the pigmented lesion treatment market in the next few years. Increasing preference for minimally invasive procedures, such as laser treatment, is likely to propel the market in the near future. Availability, effectiveness, and affordability of a wide range of laser technologies for treatment of pigmented lesions are anticipated to present lucrative growth opportunities for the market in the next few years. However, side-effects associated with laser treatment, such as itching, redness, and swelling of the skin, with chances of hyperpigmentation, scarring, blistering, and, in rare cases, infections is likely to be a major restraint of the global pigmented lesion treatment market during the forecast period.
The global pigmented lesion treatment market can be segmented based on laser type, indication type, end-user, and region. In terms of laser type, the pigmented lesion treatment market can be classified into Nd: YAG, infrared, fractional CO2, pulse-dyed lasers (PDLs), alexandrite, diode, and potassium-titanyl-phosphate. Based on indication type, the market can be broadly categorized into non-melanocytic lesions and melanocytic lesions. The non-melanocytic lesions segment can be sub-classified into benign neoplasms, inflammatory lesions, malignant neoplasms, and hamartomas. The melanocytic lesions segment can be sub-classified into benign lesions and malignant lesions. In terms of end-user, the global pigmented lesion treatment market can be classified into hospitals, skin care clinics, and others.
In terms of region, the global pigmented lesion treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for a major share of the global market, in terms of revenue, in 2017. Strong growth of the pigmented lesion treatment market in the region can be attributed to increase in investments in R&D, high awareness, favorable rules, regulations, and reimbursement policies by government bodies, and increase in health care expenditure in North America. Europe accounted for a significant share of the global market, in terms of revenue, in 2017. On the other hand, the pigmented lesion treatment market in Asia Pacific is expected to expand at a high CAGR during the forecast period, owing to Increase in geriatric population, high rate of adoption of laser technologies, and growing awareness in the region. The market in Middle East & Africa and Latin America is projected to witness moderate growth during the forecast period. This can be attributed to evolving lifestyle, increasing addiction of smoking, rising consumption of alcohol, growing sedentary lifestyle, and expanding health care service sector in these regions.
Key players operating in the global pigmented lesion treatment market are Shanghai, Fosun Pharmaceutical (Group) Co., Ltd., Solta Medical, Cutera, Hologic Inc., Lumenis, Syneron Medical Ltd., El. En. S.p.A., Lynton Lasers Ltd, STRATA Skin Sciences, and LUTRONIC.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.